Global Non-Esterified Fatty Acid Reagents Market Based on Sample Type (Serum, Plasma, Tissue Homogenate), By Based on Application (Malignant Diseases, Metabolic Syndrome, Other Applications), Based on End User (Specialty Clinics, Diagnostic Laboratories, Other End-Users) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Non-Esterified Fatty Acid Reagents Market Overview

Non-Esterified Fatty Acids (NEFA) are molecules that are liberated from triglycerides by the enzyme lipase and subsequently carried in the bloodstream bound to albumin. Non-esterified fatty acid levels must be controlled in diabetic patients, and they are commonly increasing among obese populations.

The release of non-esterified fatty acids in the body is adversely affected by insulin fluctuations and a poor diet, which can lead to cardiovascular disease. A growing patient pool is expected to fuel non-esterified fatty acid testing, in turn propelling the non-esterified fatty acid reagent market forward in the process.

Detailed Segmentation

Based on Sample Type:

• Serum
• Plasma
• Tissue Homogenate
• Cells or Cell Supernatant

Based on Application:

•  Diabetes
•  Obesity
•  Lipid Metabolism Disorders
•  Malignant Diseases
•  Metabolic Syndrome
•  Other Applications

Based on End User:

•  Hospitals
•  Outpatient Centers
•  Specialty Clinics
•  Diagnostic Laboratories
•  Other End-Users

Based on Region:

•  North America
•  Europe
•  Asia-Pacific
•  South America
•  Middle East & Africa

Market Dynamics

Drivers for the Global Non-Esterified Fatty Acid Reagents Market:

Increased non-esterified fatty acid concentrations in the blood are linked to disorders such as Type-2 diabetes and insulin resistance, obesity, metabolic syndrome, as well as cancer. This factor is expected to increase the need for non-esterified fatty acid testing, resulting in market growth for non-esterified fatty acid reagents. Furthermore, increasing obesity rates are likely to fuel the need for non-esterified fatty acid testing, further contributing to the revenue growth of the non-esterified fatty acid reagent market in the foreseeable future.

Restraints Global Non-Esterified Fatty Acid Reagents Market:

Opportunities for the Global Non-Esterified Fatty Acid Reagents Market:
According to the World Health Organization, global obesity prevalence rates tripled between 1975 and 2016. This factor has strengthened the market for non-esterified fatty acid reagents by increasing the need for non-esterified fatty acid testing. Furthermore, owing to increasing patient pools, the on-esterified fatty acid reagent market is expected to register a considerable level of expansion in the years to come.

Trends for the Global Non-Esterified Fatty Acid Reagents Market:

According to the International Diabetes Federation, by 2045, the diabetic population is expected to reach 600 million. Diabetic adults make up 79% of the population in low-, and middle-income countries. This aspect is anticipated to boost the need for non-esterified fatty acid testing, which in turn is anticipated to further augment the non-esterified fatty acid reagent market in the process.
Additionally, Healthcare professionals advise diabetic patients to monitor their body fat regularly, which will increase the demand for testing and propel the non-esterified fatty acid reagent market forward. According to the World Health Organization, roughly 1.9 billion people across the world, aged 18 and above were overweight in 2016.

Competitive Landscape

• Sekisui Diagnostics
• FUJIFILM Holdings America Corporation
• Randox Laboratories Ltd.
• Biocompare
• Cell Biolabs Inc.
• AMSBIO
• Merck KGaA
• INstruchemie Elabscience Biotechnology Inc.

For the Non-Esterified Fatty Acid Reagents Market research study, the following years have been considered to estimate the market size: